Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.

研究業績

詳細

Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models. Oyama N, Hasegawa Y, Kiyono Y, Kobayashi M, Fujibayashi Y, Ponde DE, Dence C, Welch MJ, Yokoyama O. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):81-9. doi: 10.1007/s00259-010-1613-z. Epub 2010 Sep 29. PMID: 20878403